MO

Altria's Dividend Performance: Altria Group's stock provided a total return of 13.5% over the past year, primarily due to its high dividend yield of 7.2%, although this still lagged behind the S&P 500's 15.6% return.

Declining Business Prospects: Despite the attractive dividend, Altria's core business is weakening, with a 1.3% revenue decline in smokeable products and a loss of market share, particularly for its Marlboro brand.

Investment Recommendations: Analysts suggest considering other investment options, as Altria Group was not included in the Motley Fool Stock Advisor's list of the 10 best stocks to buy, which historically have provided significant returns.

Long-term Outlook: Given the declining volume and market share, the long-term business prospects for Altria appear bleak, leading to a recommendation to avoid investing in the stock despite its high dividend yield.

Market Entry and Growth Potential: Philip Morris International has entered the U.S. market with smoke-free products like Iqos Iluma, which could significantly boost its revenue, especially as smoke-free products already account for 41% of its earnings.

Stock Performance: Despite a recent 20% drop from its peak, Philip Morris stock has risen over 24% since January, outperforming the broader market, and is considered a strong buy due to its growth prospects in the nicotine market.

FDA Approval and Future Plans: The company is awaiting FDA approval for Iqos Iluma, with expectations of a broad launch that could enhance its market share in the U.S., where traditional cigarette sales are declining.

Investment Considerations: Analysts suggest that Philip Morris could be a solid dividend stock with an estimated annual earnings growth rate of 11%, although it was not included in a recent list of top stock recommendations by the Motley Fool.